Pathfinder
AAV vs. Non-Viral Gene Delivery: Which Is Better for In Vivo Gene Therapy?
Nice Insight
PAO-26-PF-01Apr 3, 2026
RNA
Is mRNA a Gene Therapy? Unpacking the Evolving Regulatory Debate
April Stanley, MS MBA; Cynthia A. Challener, Ph.D.
Nice Insight
PAO-03-25-NI-06Mar 26, 2025
Biomarkers
The Biomarker Revolution in Medicine and Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-25-30-16Mar 10, 2025
cell therapy
State of the Cell and Gene Therapy Market
James Grote
Nice Insight
PAO-10-022-NI-01Oct 11, 2022
Column: M&A
Why the Big Shifts in Gene Therapy Investments? It’s Late in the Game
Nigel Walker
Nice Insight
PAO-03-022-NI-08Mar 23, 2022
YEAR REVIEW
2021 Roundup: The Year of Cell and Gene Therapy
David Alvaro, Ph.D.
Pharma's Almanac
PA734Dec 20, 2021
MANUFACTURING
CAR-T Cell and Gene Therapy Market: Challenges and Opportunities
Jason Rahal
Nice Insight
PA1009Apr 21, 2021
Supply Chain
Delivering Vaccines During a Pandemic
Nigel Walker
Nice Insight
PAP-Q4-20-NI-001Dec 9, 2020